News | June 23, 2026
Teva closes $700M Emalex acquisition
Bolstering neuroscience push with late-stage Tourette therapy
Bolstering neuroscience push with late-stage Tourette therapy
The double-blind, dose-finding ZUPREME-1 trial enrolled 485 adults with overweight or obesity
Partnership strengthens healthcare technology distribution capabilities, enabling wider reach of Make-in-India medical devices through government and institutional healthcare networks
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge
Developed with Wondrlab India, the 10-episode series brings together healthcare experts, a cancer survivor, and filmmaker Amole Gupte to foster meaningful conversations
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
Approval paves the way for expansion in North America’s growing vascular access market, with innovative SlipStream technology designed to simplify catheter insertion and enhance patient care
Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships
Expanded indication makes Stelo the first FDA-cleared OTC CGM for children aged two years and older with diabetes or prediabetes
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
